Anna Buxeda

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis in Kidney Transplantation.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

Identification of Differentially Expressed Genes and Pathways in Non-Diabetic CKD and Diabetic CKD by Integrated Human Transcriptomic Bioinformatics Analysis.

Journal: International journal of molecular sciences

Published: June 04, 2025

Risk assessment of antibody-mediated damage based on the detection of HLA and non-HLA antibodies toward extracellular antigens before kidney transplantation.

Journal: Frontiers in immunology

Published: April 18, 2025

Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 17, 2024

Validation of 2 Prognostic Models to Predict Renal Allograft Outcome After IgA Nephropathy Recurrence.

Journal: Kidney international reports

Published: December 01, 2024

Exercise-Based Prehabilitation for Kidney Transplant Candidates: the FRAILMar Randomized Controlled Trial.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: October 19, 2024

Corrigendum to "Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring." Kidney International 2023;103:365-377.

Journal: Kidney international

Published: September 20, 2024

Clinical and molecular spectrum of v-lesion.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: February 27, 2024

Corrigendum to "Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration" [American Journal of Transplantation 23 (2023) 464-474].

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 22, 2023

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis in Kidney Transplantation.

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis in Kidney Transplantation.

Identification of Differentially Expressed Genes and Pathways in Non-Diabetic CKD and Diabetic CKD by Integrated Human Transcriptomic Bioinformatics Analysis.

Identification of Differentially Expressed Genes and Pathways in Non-Diabetic CKD and Diabetic CKD by Integrated Human Transcriptomic Bioinformatics Analysis.

Risk assessment of antibody-mediated damage based on the detection of HLA and non-HLA antibodies toward extracellular antigens before kidney transplantation.

Risk assessment of antibody-mediated damage based on the detection of HLA and non-HLA antibodies toward extracellular antigens before kidney transplantation.

Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation.

Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation.

Validation of 2 Prognostic Models to Predict Renal Allograft Outcome After IgA Nephropathy Recurrence.

Validation of 2 Prognostic Models to Predict Renal Allograft Outcome After IgA Nephropathy Recurrence.

Exercise-Based Prehabilitation for Kidney Transplant Candidates: the FRAILMar Randomized Controlled Trial.

Exercise-Based Prehabilitation for Kidney Transplant Candidates: the FRAILMar Randomized Controlled Trial.

Corrigendum to "Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring." Kidney International 2023;103:365-377.

Corrigendum to "Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring." Kidney International 2023;103:365-377.

Clinical and molecular spectrum of v-lesion.

Clinical and molecular spectrum of v-lesion.

Corrigendum to "Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration" [American Journal of Transplantation 23 (2023) 464-474].

Corrigendum to "Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration" [American Journal of Transplantation 23 (2023) 464-474].

Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study.

Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study.

Tubulo-interstitial inflammation increases the risk of graft loss after the recurrence of IgA nephropathy.

Tubulo-interstitial inflammation increases the risk of graft loss after the recurrence of IgA nephropathy.